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Abstract
Background: The Orthopaedic Data Evaluation Panel (ODEP) monitors the performance of primary total knee
arthroplasty (TKA) implants against guidance provided by the National Institute for Health and Care Excellence
(NICE) and issues ratings based upon survivorship data meeting or exceeding 95 % at 10-year follow-up. The
objectives of the current study were to determine if the survivorship for the ADVANCE Medial-Pivot System in an
arthroplasty registry exceeds this threshold and if its survivorship is significantly different than that of all other
cemented bi-, tricompartmental, minimally stabilized, and fixed bearing TKAs in the same registry.
Methods: The database of an arthroplasty registry was searched for all TKAs performed with the subject system
and all other cemented TKAs. The Kaplan-Meier survivorship for the subject system was compared to the NICE
criteria and also that of all other cemented TKAs. Complication modes were also examined for the two groups.
Results: The 10-year survivorship for the included 506 TKAs using the subject system (96.3 %) exceeded the NICE
guidelines of 95 % at 10 years. Survivorship also exceeded that of all other cemented TKAs (95.7 %) in the same
registry, but the difference was not significantly different.
Conclusions: The subject system was associated with survivorship that exceeds the NICE guidelines at 10 years and
is similar to that of other cemented TKA systems. The use of this unique tibial insert design does not negatively
impact component survivorship.
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Background
The Orthopaedic Data Evaluation Panel (ODEP) in the
UK was established in 2002 to monitor the performance
of primary total hip arthroplasty (THA) implants against
guidance provided by the National Institute for Health
and Care Excellence (NICE) [1]. The NICE guidelines
initially stated that only THA implants with cumulative
survivorship of at least 90 % at 10-year follow-up should
be used in clinical practice [2]. In 2014, the recom-
mended survivorship was increased to at least 95 % at
10 years based upon an updated review of available
evidence [3]. While the NICE has not yet issued a
technology appraisal for total knee arthroplasty (TKA)
implants, the ODEP recently began reviewing these
implants and basing ratings upon the survivorship guide-
lines for THA. Recent annual reports for the Australian
Orthopaedic Association National Joint Replacement
Registry and the National Joint Registry for England,
Wales, Northern Ireland, and the Isle of Man reported
10-year survivorship for all cemented TKAs of 94.8 and
96.6 %, respectively [4, 5]. This suggests it is likely
reasonable for the ODEP to use the THA criteria as the
basis for its TKA ratings. These ratings and, by exten-
sion, survivorship are critically important, as some
hospitals are now requiring a minimum rating before a
device can be implanted by their surgeons.* Correspondence: david.fitch@ortho.microport.com
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The ADVANCE® Medial-Pivot System (MicroPort
Orthopedics Inc., Arlington, TN, USA) features a unique
asymmetrical tibial insert that seeks to closely mimic the
kinematics of the natural knee [6, 7]. Recently published
single-center studies using this system have reported
satisfactory midterm (5–8 years) survivorship estimates
[8–10,] and a recent meta-analysis containing data from
eight studies and over 1100 TKAs reported 99.2 % and
97.6 % survivorship at 5 and 8 years, respectively [11].
While this system has been on the market for over
17 years, there have yet to be any published reports of
long-term survivorship using it. The primary objective of
this study was to determine if the long-term survivorship
of the ADVANCE Medial-Pivot System in an arthro-
plasty registry exceeds 95 % at 10 years follow-up. The
secondary objective was to determine how the survivor-
ship for this system compared to all other cemented bi-,
tricompartmental, minimally stabilized, and fixed-bearing
TKAs in the same registry.
Methods
The database for the Register of Orthopaedic Pros-
thetic Implants (RIPO) was searched for all TKAs
implanted with the ADVANCE Medial-Pivot System
identified by product code between July 1, 2000 and
December 31, 2013. The RIPO was established at the
Istituto Ortopedico Rizzoli in the Emilia-Romagna
region of Italy and collects data related to all TKAs
and THAs performed on the region’s nearly 4.5
million residents [12]. All primary TKAs implanted
with the subject system were included in the analysis.
TKAs were excluded if they were implanted in
patients who lived outside of the Emilia-Romagna
region to minimize bias due to loss to follow-up. For
residents of the Emilia-Romagna region, any treatment
received in other regions of Italy is billed back to the
Emilia-Romagna region and therefore captured in the
registry. For residents of other regions that had their
TKA performed in the Emilia-Romagna region, future
treatment received outside of the Emilia-Romagna
region is billed to their home region and therefore not
captured in the registry. Due to these limitations of
the registry and healthcare system, the most accurate
and simplest method to minimize bias and not over-
estimate survivorship was to use only data from the
Emilia-Romagna region. For the same time period,
data was also retrieved for all other bi-, tricom-
partmental, minimally stabilized, and fixed-bearing
cemented TKAs to serve as a comparison group.
Ethics approval was not necessary as the data was
collected from a registry in Italy that collects data as
standard practice on all patients in their region.
Additionally, all data was collected and analyzed in a
de-identified format that protects patient privacy.
Statistical considerations
For both cohorts, subject demographics and reasons for
revision were presented as a percentage of the total
cohort. Patient age and body mass index were compared
using a t test (p < 0.05), while gender and indication
for surgery were compared using chi-square analysis
(p < 0.05). Kaplan-Meier survivorship analysis was per-
formed using revision of any component as the end-
point and survival times of unrevised TKAs taken as
the last date of observation (December 31, 2013 or
date of death). The log-rank test was used to com-
pare survivorship between the two groups. The Cox
multiple regression model for analyzing survival data
was considered. The proportionality hazards assump-
tion was tested by the Schoenfeld residual method;
age and gender used for adjustment fulfilled the pro-
portional hazard assumption for the all period.
The Wald test was used to calculate the p values for
data obtained from the Cox multiple regression analyses.
Differences between groups were considered statisti-
cally significant if the p values were less than 0.05. All
statistical analyses were performed using SPSS software
(version 14.0.1, Chicago, Illinois).
Results
There were 506 TKAs performed with the subject
system by 30 orthopedic surgeons at more than ten
hospitals during the time period of interest. A large
majority of patients were female (72.3 %), and over 70 %
were considered overweight or obese (Table 1). All com-
ponents were implanted with cemented fixation, and the
patella was resurfaced in only three (0.6 %) TKAs. The
mean follow-up was 6.6 years (range, 0.02–13.0), and
Table 1 Demographics for patients in the two study groups
ADVANCE All Other Cemented TKAs
Mean age (years) 73.4 (24–90) 71.7 (24–92)
Male (%)/female (%) 27.7 %/72.3 % 29.0 %/71.0 %
Body mass index
Underweight (≤19) 0.2 % 0.2 %
Normal (20–25) 27.8 % 19.3 %
Overweight (26–29) 45.5 % 46.4 %
Obese (≥30) 26.4 % 34.1 %
Indication for TKA
Primary arthritis (%) 89.9 % 87.1 %
Deformity (%) 3.4 % 6.9 %
Rheumatoid arthritis (%) 2.4 % 1.3 %
Post-traumatic arthritis (%) 2.2 % 1.2 %
Chondrocalcinosis (%) 1.0 % 1.0 %
Sequelae of osteotomy (%) 0.6 % 0.8 %
Other (%) 0.6 % 1.7 %
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there were no intraoperative complications reported
for any patient during hospitalization. Demographics
for the 20,446 TKAs included in the All Other
Cemented TKAs group were similar to those of the
ADVANCE group (Table 1). There were no statis-
tical differences in body mass index, age, or gender
between the two groups. Patients in the All Other
Cemented TKAs group were significantly younger
(p = 0.001).
The Kaplan-Meier survivorship estimate at 10 years
was 96.3 % (95 % CI, 94.5–98.1) for the ADVANCE
group (Table 2). In this table, N at Risk refers to the
number of TKAs that were available at the beginning of
each year interval. This was higher than the 10-year rate
of 95.7 % (95 % CI, 95.3–96.2) for the All Other Cemen-
ted TKAs group (Table 3), but the difference was not
statistically significant (Fig. 1). There were 16 (3.1 %)
revisions in the ADVANCE group: 9 for aseptic loosen-
ing where both the tibial and femoral components were
revised; 5 for septic loosening; and 2 for aseptic loosen-
ing where only the tibial component was revised
(Table 4). The adjusted risk of revision was not signifi-
cantly different for the ADVANCE and All Other
Cemented TKAs groups. (p = 0.662). Results of the Cox
regression analysis showed age at the time of surgery
was the only variable influencing the risk of revision for
any cause, with the risk of revision decreasing as the age
at the time of surgery increased.
Table 2 Survivorship estimates and numbers at risk for the ADVANCE group
Year Survivorship (%) Lower 95 % CI Upper 95 % CI N Revisions N Deaths N At Risk
0 100.0 100.0 100.0 1 7 506
1 99.2 98.4 100.0 5 4 494
2 98.1 96.9 99.3 5 7 459
3 97.6 96.3 99.0 2 10 424
4 97.2 95.6 98.7 0 8 397
5 96.6 94.9 98.3 2 9 367
6 96.6 94.9 98.3 0 10 334
7 96.3 94.5 98.1 1 16 290
8 96.3 94.5 98.1 0 12 230
9 96.3 94.5 98.1 0 12 173
10 96.3 94.5 98.1 0 4 113
11 96.3 94.5 98.1 0 1 58
12 96.3 94.5 98.1 0 0 18
13 96.3 94.5 98.1 0 0 1
Table 3 Survivorship estimates and numbers at risk for the All Other Cemented TKAs group
Year Survivorship (%) Lower 95 % CI Upper 95 % CI N Revisions N Deaths N At Risk
0 100.0 100.0 100.0 122 163 20,446
1 99.4 99.3 99.5 119 181 19,342
2 98.7 98.5 98.8 102 234 17,070
3 98.0 97.8 98.2 47 253 14,890
4 97.6 97.4 97.9 32 249 12,799
5 97.4 97.1 97.6 15 246 10,787
6 97.2 96.9 97.5 23 232 8801
7 96.9 96.6 97.2 23 219 6931
8 96.4 96.1 96.8 20 190 5317
9 96.0 95.6 96.4 6 138 3950
10 95.7 95.3 96.2 4 112 2776
11 95.5 95.1 96.0 4 63 1835
12 95.2 94.6 95.8 0 36 1060
13 95.2 94.6 95.8 0 4 436
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Discussion
The current study is the first to report long-term
survivorship in patients implanted with the ADVANCE
Medial-Pivot System. The 10-year component survivor-
ship of 96.3 % for this large series of patients exceeded
the 95 % threshold recommended by the NICE in the
UK. This outcome was expected as the existing midterm
publications for this system show survivorship estimates
that are equivalent to or exceed the thresholds at 5
(97.5 %) and 7 (96.5 %) years follow-up [8–10, 13]. The
current results are particularly encouraging in that they
were collected by 30 surgeons at over ten centers and
independently analyzed by an arthroplasty registry.
Between the late 1990s and the early 2000s, several
studies examined the kinematics of the “natural knee”
[14–16]. These studies concluded that throughout flexion,
the medial condyle experiences very little antero-posterior
motion while the lateral condyle moves in a pivot motion
around the medial condyle. Komistek et al. showed that
this motion was observed during several common activ-
ities including deep knee bends, chair rise, chair sit, and
level walking [16]. The subject system features a unique
tibial insert design that constrains motion in the medial
compartment while allowing unrestricted motion in the
lateral compartment. The tibial insert also features anter-
ior and posterior lips, which seek to provide enhanced
anterior-posterior stability by substituting for both the
anterior and posterior cruciate ligaments. Fluoroscopic
analysis has shown that this design results in motion that
is similar to that of the natural knee described previously
[6, 7]. It has also been associated with increased quadri-
ceps efficiency and reduced compensation in contralateral
legs when compared to patients implanted with posterior-
stabilized tibial insert designs during inclined walking [17]
and sit-to-stand tasks [18]. Another report showed that
patients with bilateral TKAs preferred the subject system
over posterior-stabilized, mobile-bearing, and posterior
cruciate ligament retaining TKA systems implanted in the
contralateral knee [19]. The author attributed this prefer-
ence to the design providing anterior-posterior stability
and in turn, an increased feeling of stability.
While the subject design has been shown to closely
replicate the natural motion of the knee and be preferred
over some implant designs, a recent publication has
speculated that the anterior region of the insert may
experience additional stress because the anterior motion
of the medial femoral condyle is suppressed only by the
geometry of the insert [6]. If increased stresses existed,
they could manifest themselves as failures due to in-
creased insert wear, instability, insert breakage, or loos-
ening. To determine if this unique design does result in
reduced long-term outcomes, the survivorship for the
system was compared to that for all other cemented
Fig. 1 Survivorship estimates for the ADVANCE (blue line) and the All
Cemented TKAs (red lines) are shown with their associated 95 %
confidence intervals
Table 4 Reasons for revision for the ADVANCE and All Other Cemented TKAs groups
Reason for revision ADVANCE Medial-Pivot All Other Cemented TKAs
N % N %
Aseptic loosening—both components revised 9 1.77 150 0.73
Septic loosening 5 0.98 141 0.69
Aseptic loosening—only tibia revised 2 0.39 42 0.21
Pain without loosening 0 0 67 0.33
Liner wear 0 0 22 0.11
Aseptic loosening—only femur revised 0 0 15 0.07
Instability 0 0 15 0.07
Dislocation 0 0 14 0.07
Bone fracture 0 0 13 0.06
Breakage of prosthesis 0 0 5 0.02
Unknown 0 0 15 0.07
Other 0 0 18 0.09
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TKAs. The survivorship for the subject system was not
significantly different than that reported for All Other
Cemented TKAs in the RIPO, suggesting this design
does not negatively impact longevity when compared to
other available systems.
Limitations
There are several limitations to the current study. First, the
study design is retrospective and the data source is a
regional registry, meaning data might not be applicable to
other geographic regions or cultures (e.g., Asian cultures
which perform more deep flexion activities). Second, the
only endpoint analyzed is survivorship. While the ODEP
only analyzes survivorship and study quality in their assess-
ments of devices, other outcomes (e.g., functional out-
comes, satisfaction) are needed to determine if a procedure
should be considered a success for a patient. Third, the
survivorship for the subject system exceeded the NICE
guideline of 95 %, but the lower bound of the confidence
interval (94.5 %) was slightly less. This suggests there is a
slight possibility that the actual survivorship could be below
the NICE guideline. Fourth, the ASA-status or other meas-
ure of functional status was not available as part of this
dataset. Finally, the registry only captures postoperative
complications that resulted in revision. This could lead to
an underestimation of complications that occurred but did
not require revision (e.g., infections).
Conclusions
Results from the current study of over 500 TKAs show
that component survivorship at 10 years for the sub-
ject system exceeds the NICE guidelines. Survivorship
was also similar to other cemented bi-, tricompa-
rtmental, minimally stabilized, and fixed-bearing de-
signs, suggesting that the use of this unique tibial
insert design does not adversely impact outcomes
when compared to other designs.
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